672 related articles for article (PubMed ID: 8120917)
21. Breast cancer among young U.S. women in relation to oral contraceptive use.
White E; Malone KE; Weiss NS; Daling JR
J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
[TBL] [Abstract][Full Text] [Related]
22. [Can breast cancer be prevented?].
Vatten LJ
Tidsskr Nor Laegeforen; 1991 May; 111(14):1745-8. PubMed ID: 2063386
[TBL] [Abstract][Full Text] [Related]
23. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer.
Pike MC; Ross RK
Steroids; 2000; 65(10-11):659-64. PubMed ID: 11108873
[TBL] [Abstract][Full Text] [Related]
24. Hormones and risk of breast cancer.
Onnis A; Marchetti M; Graziottin A
Eur J Gynaecol Oncol; 1983; 4(1):13-7. PubMed ID: 6305660
[TBL] [Abstract][Full Text] [Related]
25. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
26. Reduced mammographic density with use of a gonadotropin-releasing hormone agonist-based chemoprevention regimen in BRCA1 carriers.
Weitzel JN; Buys SS; Sherman WH; Daniels A; Ursin G; Daniels JR; MacDonald DJ; Blazer KR; Pike MC; Spicer DV
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):654-8. PubMed ID: 17255289
[TBL] [Abstract][Full Text] [Related]
27. GnRH agonists as contraceptive agents: predicted significantly reduced risk of breast cancer.
Spicer DV; Shoupe D; Pike MC
Contraception; 1991 Sep; 44(3):289-310. PubMed ID: 1662596
[TBL] [Abstract][Full Text] [Related]
28. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
29. Hormonal contraception.
Baird DT; Glasier AF
N Engl J Med; 1993 May; 328(21):1543-9. PubMed ID: 8479492
[TBL] [Abstract][Full Text] [Related]
30. Hormonal contraception and lactation.
Kelsey JJ
J Hum Lact; 1996 Dec; 12(4):315-8. PubMed ID: 9025449
[TBL] [Abstract][Full Text] [Related]
31. Immune reactivity of women on hormonal contraceptives. Phytohemagglutinin and concanavalin-A induced lymphocyte response.
Gerretsen G; Kremer J; Bleumink E; Nater JP; de Gast GC; The TH
Contraception; 1980 Jul; 22(1):25-9. PubMed ID: 7418405
[TBL] [Abstract][Full Text] [Related]
32. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review.
Gambrell RD; Bagnell CA; Greenblatt RB
Am J Obstet Gynecol; 1983 Jul; 146(6):696-707. PubMed ID: 6307050
[TBL] [Abstract][Full Text] [Related]
33. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
34. Oral progestogen-only contraception may protect against loss of bone mass in breast-feeding women.
Caird LE; Reid-Thomas V; Hannan WJ; Gow S; Glasier AF
Clin Endocrinol (Oxf); 1994 Dec; 41(6):739-45. PubMed ID: 7889609
[TBL] [Abstract][Full Text] [Related]
35. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
36. Contraception and the big "C".
Chandran R
Malays J Reprod Health; 1992 Jun; 10(1):1-5. PubMed ID: 12345024
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for breast cancer in women undergoing mammography.
Reuter KL; Baker SP; Krolikowski FJ
AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
[TBL] [Abstract][Full Text] [Related]
38. Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.
Byrne C; Ursin G; Martin CF; Peck JD; Cole EB; Zeng D; Kim E; Yaffe MD; Boyd NF; Heiss G; McTiernan A; Chlebowski RT; Lane DS; Manson JE; Wactawski-Wende J; Pisano ED
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28376149
[TBL] [Abstract][Full Text] [Related]
39. Treatment of breast cancer with medroxyprogesterone acetate.
Muggia FM; Cassieth PA; Ochoa M; Flatow FA; Gellhorn A; Hyman GA
Ann Intern Med; 1968 Feb; 68(2):328-37. PubMed ID: 4306126
[TBL] [Abstract][Full Text] [Related]
40. Long-acting hormonal contraception.
Bromham DR
Ann N Y Acad Sci; 1997 Jun; 816():432-9. PubMed ID: 9238299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
